150 related articles for article (PubMed ID: 15148978)
1. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
[No Abstract] [Full Text] [Related]
2. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced hyperkalaemia is frequent.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17323523
[TBL] [Abstract][Full Text] [Related]
4. Drug safety in patients with heart failure.
Juurlink DN; Hansten PD
Arch Intern Med; 2005 Jan; 165(1):118. PubMed ID: 15642888
[No Abstract] [Full Text] [Related]
5. Diabetes may be independent risk factor for hyperkalaemia.
Jarman PR; Mather HM
BMJ; 2003 Oct; 327(7418):812. PubMed ID: 14525902
[No Abstract] [Full Text] [Related]
6. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
Berry C; McMurray J
Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
[No Abstract] [Full Text] [Related]
7. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
8. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
Erden I; Yalcin S; Ozhan H
Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
[TBL] [Abstract][Full Text] [Related]
9. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
Gottlieb S
BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321896
[No Abstract] [Full Text] [Related]
10. [Let's read the domestic literature. ACE-inhibitors and spironolactone-induced hyperkalemia].
Radó J
Orv Hetil; 2002 Aug; 143(31):1868; author reply 1868. PubMed ID: 12187583
[No Abstract] [Full Text] [Related]
11. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
Konopa J; Bułło B; Rutkowski B
Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
[TBL] [Abstract][Full Text] [Related]
12. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
Jarman PR; Keheley AM; Mather HM
Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
[No Abstract] [Full Text] [Related]
13. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
Odawara M; Asano M; Yamashita K
Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
[No Abstract] [Full Text] [Related]
14. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
Cruz CS; Cruz LS; Domingues GS; Souza CA
Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
[TBL] [Abstract][Full Text] [Related]
15. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
16. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
Schepkens H; Vanholder R; Billiouw JM; Lameire N
Am J Med; 2001 Apr; 110(6):438-41. PubMed ID: 11331054
[TBL] [Abstract][Full Text] [Related]
17. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
Cruz CS; Cruz AA; Marcílio de Souza CA
Nephrol Dial Transplant; 2003 Sep; 18(9):1814-9. PubMed ID: 12937229
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
Dinsdale C; Wani M; Steward J; O'Mahony MS
Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
[No Abstract] [Full Text] [Related]
19. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
[No Abstract] [Full Text] [Related]
20. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations.
Prescrire Int; 2000 Oct; 9(49):158-9. PubMed ID: 11603418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
